Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
Web Exclusives
Can Therapeutic Decisions Be Based on Cytogenetic Findings?
Web Exclusives
In recent years, a better understanding of the biology and molecular pathology of multiple myeloma (MM) has resulted in significant therapeutic milestones.
Read More
Considerations in Benefit Design for Multiple Myeloma
Web Exclusives
In this newsletter, we will discuss benefit design considerations for multiple myeloma, with a focus on treatment pathways and information technologies that can be used to improve patient care.
Read More
Bone Disease in Multiple Myeloma
Web Exclusives
In this fifth issue, we will focus on the economic implications of newer agents used to treat myeloma-related bone disease.
Read More
Side Effect Management in the Treatment of Multiple Myeloma
Web Exclusives
In this fourth issue, we will focus on the value of incorporating best practices for managing treatment-related toxicities.
Read More
Renal Impairment in Multiple Myeloma
Web Exclusives
In this third issue, we will be focusing on the impact of novel agents on myeloma-associated renal impairment.
Read More
Relevance of End Points in Clinical Trials for Multiple Myeloma
Web Exclusives
In this second issue, we will focus on the relevance of end points in clinical trials for myeloma.
Read More
The Importance of Cytogenetic Testing for Patients with Multiple Myeloma
Web Exclusives
This first newsletter will discuss guided therapeutic choices based on the presence of high-risk cytogenetic abnormalities.
Read More
Page 4 of 4
1
2
3
4
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.